Security key
880881107
Terns Pharmaceuticals, Inc. - Common Stock (TERN)
CUSIP: 880881107
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 79,491,087
- Total 13F value
- $663,002,763
- Share change
- +13,216,550
- Put/Call ratio
- 78%
- SEC-reported price per share
- $8.34
- Number of holders
- 153
- Value change
- +$119,235,330
- Number of buys
- 100
- Number of sells
- 59
- Shares outstanding
- 115,479,185
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
153
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of TERN - Terns Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
153
Shares
79,491,087
Rows available
153
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
124
Q3 2024 holders
153
Holder diff
29
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|